Chromomycin A2 exhibits antileukemic effects by coordinated disruption of survival pathways (2025)
- Authors:
- USP affiliated authors: LOTUFO, LETICIA VERAS COSTA - ICB ; MACHADO NETO, JOÃO AGOSTINHO - ICB ; REGO, EDUARDO MAGALHÃES - FM ; LIMA, KELI CRISTINA DE - FM ; MEDEIROS, RITA DE CÁSSIA CAVAGLIERI - FM ; NOGUEIRA, FREDERICO LISBOA - FM
- Unidades: ICB; FM
- DOI: 10.1182/blood-2025-7848
- Assunto: FARMACOLOGIA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2025
- Source:
- Conference titles: ASH - Annual Meeting and Exposition
- Este artigo NÃO possui versão em acesso aberto
-
Status: Nenhuma versão em acesso aberto identificada -
ABNT
LIMA, Keli Cristina de et al. Chromomycin A2 exhibits antileukemic effects by coordinated disruption of survival pathways. Blood. Washington: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2025-7848. Acesso em: 11 mar. 2026. , 2025 -
APA
Lima, K. C. de, Vieira, E., Medeiros, R. de C. C., Nogueira, F. L., Costa-Lotufo, L. V., Machado Neto, J. A., & Rego, E. M. (2025). Chromomycin A2 exhibits antileukemic effects by coordinated disruption of survival pathways. Blood. Washington: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1182/blood-2025-7848 -
NLM
Lima KC de, Vieira E, Medeiros R de CC, Nogueira FL, Costa-Lotufo LV, Machado Neto JA, Rego EM. Chromomycin A2 exhibits antileukemic effects by coordinated disruption of survival pathways [Internet]. Blood. 2025 ; 146[citado 2026 mar. 11 ] Available from: https://doi.org/10.1182/blood-2025-7848 -
Vancouver
Lima KC de, Vieira E, Medeiros R de CC, Nogueira FL, Costa-Lotufo LV, Machado Neto JA, Rego EM. Chromomycin A2 exhibits antileukemic effects by coordinated disruption of survival pathways [Internet]. Blood. 2025 ; 146[citado 2026 mar. 11 ] Available from: https://doi.org/10.1182/blood-2025-7848 - Translational investigation of tolinapant (ASTX660) in acute myeloid leukemia by integrating clinical, bioinformatic and pharmacological approaches
- Clinical significance of Philadelphia-like-related genes in a resource-constrained setting of adult B-acute lymphoblastic leukemia patients
- Synthesis and evaluation of 2-substituted quinazolin-4(3H)-ones as potential antileukemic agents
- In Silico, in vitro, and in vivo studies of a 2-substituted quinazolin-4(3H)-one in T-cell acute lymphoblastic leukemia
- Cellular and molecular effects of Eribulin in preclinical models of hematologic neoplasms
- All-trans retinoic acid potentiates cell death induced by quizartinib in acute myeloid leukemia with FLT3-ITD mutations
- Identification of vulnerabilities for pharmacological inhibition of PIP4K2s in Acute Myeloid Leukemia
- Pharmacological PIP4K2 inhibition disrupts mitochondrial homeostasis and autophagy in acute leukemia
- Metabolic reprogramming represents a targetable mechanism to overcome acquired resistance to venetoclax in acute myeloid leukemia
- Metabolic reprogramming drives acquired venetoclax resistance in Acute Myeloid Leukemia and reveals targetable vulnerabilities
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
